Contact this trialFirst, we need to learn more about you.
NMDA Receptor Antagonist
Ketamine + eCBT for PTSD
Recruiting3 awardsPhase 2
Kingston, Ontario
This trial tests a new treatment for PTSD using low-dose Ketamine infusions and online therapy. It targets patients who haven't improved with other treatments. Ketamine affects brain chemicals related to mood, while the therapy helps change negative thoughts. The goal is to see if this combination works better than other treatments. Ketamine is currently used in treating multiple pain, mental health, and substance abuse disorders due to its rapid-acting analgesic and antidepressant effects.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service